Coccidioidomycosis in Solid Organ Transplantation
Clinical Infectious Diseases2001Vol. 33(9), pp. 1536–1544
Citations Over TimeTop 10% of 2001 papers
Abstract
Coccidioidomycosis is an endemic fungal infection of the southwestern United States. Normally a self-limited infection in healthy hosts, coccidioidomycosis can become a serious complication in patients who have had solid organ transplantation. Among patients whose solid organ transplantation was complicated by coccidioidomycosis, the infection has a variety of clinical presentations. Disseminated disease is common and has substantial morbidity. Patients at risk for coccidioidal infection should be identified so that antifungal prophylactic therapy can be initiated. Treatment options include amphotericin B or azoles. Secondary prophylaxis is recommended because relapse is frequent.
Related Papers
- → Antileishmanial activity of nano-amphotericin B deoxycholate(2008)76 cited
- → Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy(2010)31 cited
- → Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis 1(1982)157 cited
- → Synergistic action of amphotericin B and rifampin against Rhizopus species(1987)63 cited
- → In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits(1997)7 cited